The trial is spearheaded by Dr Jonathan Hernandez, the surgical oncology section chief of the National Cancer Institute.

University of Kentucky Markey Cancer Center researcher Weisi Yan, M.D., Ph.D., recently shared his work on radiation therapy ...

XOMA Royalty’s acquisition of Turnstone Biologics highlights how royalty deals can revive biopharma companies and drive ...

The most imaginative zodiac sign deserves a blanket to help them dream big. Pisces is an empathetic and deeply intuitive sign ...

Wade Douglas stands at the meeting point of surgical excellence and medical education, where his two decades of experience have shaped both patient outcomes and the next generation of surgeons. His ...

New research reveals critical gaps in treatment for advanced non–small cell lung cancer (NSCLC), emphasizing the need for ...